Table 3.
Clinical variables associated with 36+ month weight loss (N=857).
Estimate | SE | p-value | |
---|---|---|---|
Intercept | 56.7 | 3.6 | |
Baseline BMI | |||
35-39.9 | 40.9 | 4.3 | <.0001 |
40-49.9 | 16.4 | 2.9 | <.0001 |
50-59.9 | 3.5 | 2.9 | 0.230 |
60+ | Reference | ||
Diabetes group | |||
Any diabetes medication | −5.3 | 1.7 | 0.0024 |
Use of bupropion | |||
Active use of medication | 6.4 | 2.8 | 0.0244 |
Smoking | |||
History of smoking | 4.8 | 2.2 | 0.0300 |
Age and surgical access | |||
Age 50+ with Laparoscopic surgery | Reference | ||
Age 50+ with Open surgery | −9.5 | 2.7 | 0.0004 |
Age<50 with Laparoscopic surgery | −3.9 | 2.6 | 0.135 |
Age<50 with Open surgery | −4.9 | 2.6 | 0.062 |
Liver pathology and baseline BMI | |||
No fibrosis | Reference | ||
Any Fibrosis with baseline BMI<50 kg/m2 | −13.4 | 4.3 | 0.0020 |
Any Fibrosis with baseline BMI 50+ kg/m2 | −0.1 | 4.6 | 0.974 |